Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)-Reference-Cited by-同舟云学术

Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)

Published:2010-02 Issue:3 Volume:148 Page:386-393
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Alatrash Gheath,Albitar Maher,OâBrien Susan,Wang Xuemei,Manshouri Taghi,Faderl Stefan,Ferrajoli Alessandra,Burger Jan,Garcia-Manero Guillermo,Kantarjian Hagop M.,Lerner Susan,Keating Michael J.,Wierda William G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07965.x/fullpdf

Reference20 articles.

1. Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies;Albitar;Cancer,2004

2. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray;Belov;Cancer Research,2001

3. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment;Cheson;Blood,1996

4. Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils;Elsner;Blood,1996

5. Circulating CD20 and CD52 in patients with non-Hodgkinâs lymphoma or Hodgkinâs disease;Giles;British Journal Haematology,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer;Gene;2024-11

2. Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis;Journal of Clinical Medicine;2024-08-29

3. CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma;Pigment Cell & Melanoma Research;2023-11-17

4. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis;Journal of Cellular Physiology;2019-05-02

5. Resistance to Monoclonal Antibody Therapeutics in Lymphoma;Resistance to Targeted Anti-Cancer Therapeutics;2019